Evidence map›Paper›PMID 31182723›Full record

ArticleScientific reports2019

A mathematical model of tumor-endothelial interactions in a 3D co-culture.

Yamicia Connor, Yonatan Tekleab, Sarah Tekleab, Shyama Nandakumar, Divya Bharat, Shiladitya Sengupta

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yamicia ConnorHarvard-MIT Division of Health Sciences and Technology, Cambridge, MA, 02139, USA.
Yonatan TekleabMassachusetts Institute of Technology, Department of Aeronautics and Astronautics, Cambridge, MA, 02139, USA.
Sarah TekleabBrigham and Women's Hospital, Department of Medicine, Boston, MA, 02115, USA.
Shyama NandakumarBrigham and Women's Hospital, Department of Medicine, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0003-0624-3452
Divya BharatBrigham and Women's Hospital, Department of Medicine, Boston, MA, 02115, USA.
Shiladitya SenguptaHarvard-MIT Division of Health Sciences and Technology, Cambridge, MA, 02139, USA. shiladit@mit.edu.
Brigham and Women's Hospital · USAmerican Institute of Aeronautics and Astronautics · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Engineering personalized micro-tumor ecosystemsU01CA214411 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHADEMHOSSEINI, ALI, SENGUPTA, SHILADITYA · 2017 to 2021
$3.5M
Whitlockite nanoparticle-based immunotherapy for bone metastasisR01CA236702 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI JANG, HAE LIN, SENGUPTA, SHILADITYA · 2019 to 2023
$2.7M
Spatiotemporal delivery of synergistic drug combinations to kidney cancerR01CA229772 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI SABBISETTI, VENKATA · 2018 to 2022
$1.9M
Multifunctional nanoparticles for targeting aberrant tumorigenic pathwaysR01CA135242 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI SENGUPTA, SHILADITYA · 2010 to 2014
$1.8M
NCATS NIH HHS UL1 TR001102NCI NIH HHS R01 CA135242NCI NIH HHS R01 CA229772NCI NIH HHS R01 CA236702NCI NIH HHS U01 CA214411NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Intravasation and extravasation of cancer cells through blood/lymph vessel endothelium are essential steps during metastasis. Successful invasion requires coordinated tumor-endothelial crosstalk, utilizing mechanochemical signaling to direct cytoskeletal rearrangement for transmigration of cancer cells. However, mechanisms underlying physical interactions are difficult to observe due to the lack of experimental models easily combined with theoretical models that better elucidate these pathways. We have previously demonstrated that an engineered 3D in vitro endothelial-epithelial co-culture system can be used to isolate both molecular and physical tumor-endothelial interactions in a platform that is easily modeled, quantified, and probed for experimental investigation. Using this platform with mathematical modeling, we show that breast metastatic cells display unique behavior with the endothelium, exhibiting a 3.2-fold increase in interaction with the endothelium and a 61-fold increase in elongation compared to normal breast epithelial cells. Our mathematical model suggests energetic favorability for cellular deformation prior to breeching endothelial junctions, expending less energy as compared to undeformed cells, which is consistent with the observed phenotype. Finally, we show experimentally that pharmacological inhibition of the cytoskeleton can disrupt the elongatation and alignment of metastatic cells with endothelial tubes, reverting to a less invasive phenotype.

Indexed as

Cell CommunicationCoculture TechniquesModels, TheoreticalCell Line, TumorCytoskeletonEpithelial CellsHumansHuman Umbilical Vein Endothelial CellsNeoplasm InvasivenessNeoplasm MetastasisNeoplasmsPhenotype

Identifiers

PMID31182723
PMCPMC6557844
OpenAlexW2951135248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.